0001140361-22-044631.txt : 20221206 0001140361-22-044631.hdr.sgml : 20221206 20221206185209 ACCESSION NUMBER: 0001140361-22-044631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221202 FILED AS OF DATE: 20221206 DATE AS OF CHANGE: 20221206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Singer Nicholas Jason CENTRAL INDEX KEY: 0001828224 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11460 FILM NUMBER: 221448840 MAIL ADDRESS: STREET 1: 1395 BRICKELL AVENUE STREET 2: SUITE 800 CITY: MIAMI STATE: FL ZIP: 33131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eterna Therapeutics Inc. CENTRAL INDEX KEY: 0000748592 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 311103425 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10355 SCIENCE CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (212) 582-1199 MAIL ADDRESS: STREET 1: 10355 SCIENCE CENTER DRIVE STREET 2: SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Brooklyn ImmunoTherapeutics, Inc. DATE OF NAME CHANGE: 20210325 FORMER COMPANY: FORMER CONFORMED NAME: NTN BUZZTIME INC DATE OF NAME CHANGE: 20051230 FORMER COMPANY: FORMER CONFORMED NAME: NTN COMMUNICATIONS INC DATE OF NAME CHANGE: 19920703 4 1 form4.xml X0306 4 2022-12-02 0000748592 Eterna Therapeutics Inc. ERNA 0001828224 Singer Nicholas Jason C/O ETERNA THERAPEUTICS INC. 10355 SCIENCE CENTER DRIVE, SUITE 150 SAN DIEGO CA 92121 true Common Stock 2022-12-02 4 P 0 70822 3.28 A 121822 I By Purchase Capital LLC Common Stock 2022-12-02 4 P 0 212464 3.28 A 266214 I By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer Warrants (right to buy) 3.28 2022-12-02 4 P 0 141644 0.125 A 2023-06-02 2028-06-02 Common Stock, par value $0.005 per share 141644 141644 I By Purchase Capital LLC Warrants (right to buy) 3.28 2022-12-02 4 P 0 424928 0.125 A 2023-06-02 2028-06-02 Common Stock, par value $0.005 per share 424928 424928 I By Pacific Premier Trust, Custodian, FBO Nicholas J. Singer The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 283,286 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules. /s/ Nicholas J. Singer 2022-12-06